1. AbobotulinumtoxinA in the Management of Hallux Valgus in Adult Patients: Results of a Randomised And Placebo-Controlled Phase 2 Trial. Issue 4 (22nd October 2020) Authors: Silva, Robert; Parekh, Selene G.; DiDomenico, Lawrence A.; Armstrong, David G.; Baravarian, Babak; Volteau, Magali Journal: Foot & ankle orthopaedics Issue: Volume 5:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AbobotulinumtoxinA in the management of hallux valgus in adult patients: Results of a randomized and placebo-controlled Phase II trial. (January 2021) Authors: Parekh, Selene G.; Armstrong, David G.; DiDomenico, Lawrence A.; Baravarian, Babak; Volteau, Magali; Silva, Robert Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2). Issue 1 (2nd November 2022) Authors: Denys, Pierre; Castaño Botero, Juan Carlos; Vita Nunes, Ricardo Luis; Wachs, Barton; Mendes Gomes, Cristiano; Krivoborodov, Grigory; Tu, Le Mai; Del‐Popolo, Giulio; Thompson, Catherine; Vilain, Claire; Volteau, Magali; Kennelly, Michael Journal: Neurourology and urodynamics Issue: Volume 42:Issue 1(2023) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. (19th March 2021) Authors: Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe Journal: Aesthetic surgery journal Issue: Volume 41:Number 11(2021) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dose‐Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study. Issue 1 (19th June 2017) Authors: O'Dell, Michael W.; Brashear, Allison; Jech, Robert; Lejeune, Thierry; Marque, Philippe; Bensmail, Djamel; Ayyoub, Ziyad; Simpson, David M.; Volteau, Magali; Vilain, Claire; Picaut, Philippe; Gracies, Jean Michel Journal: PM&R Issue: Volume 10:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. J07 What can we learn from a phase ii study with BN82451B in hd beyond safety and tolerability – clinical versus objective motor measures. (September 2018) Authors: Bohlen, Stefan; Paty, Isabelle; Volteau, Magali; Meyer, Ingo; Rein, Werner; Kosinski, Christoph; Reilmann, Ralf Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment. Issue 11 (7th November 2022) Authors: Hilton, Said; Kestemont, Philippe; Sattler, Gerhard; Volteau, Magali; Thompson, Catherine; Andriopoulos, Bill; Prygova, Inna; Berg, Anna-Karin; Ascher, Benjamin Journal: Dermatologic surgery Issue: Volume 48:Issue 11(2022) Page Start: 1198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial. (14th February 2017) Authors: Ascher, Benjamin; Kestemont, Philippe; Boineau, Dominique; Bodokh, Isaac; Stein, Annette; Heckmann, Marc; Dendorfer, Markus; Pavicic, Tatjana; Volteau, Magali; Tse, Anissa; Picaut, Philippe; Rzany, Berthold Journal: Aesthetic surgery journal Issue: Volume 38(2018)Supplement 2 Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. (20th March 2019) Authors: Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe Journal: Aesthetic surgery journal Issue: Volume 40:Number 1(2020) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term efficacy and safety of abobotulinumtoxinA solution for the treatment of moderate-to-severe glabellar lines: A Phase III, double-blind, placebo-controlled and open-label repeat injection study. (January 2021) Authors: Kestemont, Philippe; Hilton, Said; Andriopoulos, Bill; Prygova, Inna; Thompson, Catherine; Volteau, Magali; Ascher, Benjamin Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗